Bristol-Myers Squibb
Develops medicines for cancer, blood disorders, immunology, cardiovascular disease and neuroscience.
$66.60
After-hours close+0.03 (+0.05%)
At close$66.57(−0.57%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 94.10%1.92B sharesInsiders 0.05%934.7K sharesOther 5.85%119.54M shares
Shares outstanding 2.04B · Float 2.04B · 99.9% free float
Institutions13F, as of Jun 30, 2026
2,609 holders · 1.92B shares · 186 new positions · 1,177 increased · 1,004 reduced · 206 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 180.38M | 8.83% | +8.70M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 133.34M | 6.53% | +1.02M | Aug 13, 2026 |
| State Street Corp | 102.41M | 5.01% | +3.84M | Aug 7, 2026 |
| JPMorgan Chase & Co | 71.71M | 3.51% | −20.76M | Aug 12, 2026 |
| Charles Schwab Investment Management Inc | 67.60M | 3.31% | +6.48M | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 67.60M | 3.31% | +67.60Mnew | Aug 14, 2026 |
| Geode Capital Management, LLC | 56.44M | 2.76% | +1.16M | Aug 12, 2026 |
| Vanguard Portfolio Management LLC | 46.87M | 2.29% | +642.9K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 153.11M | 13G | Apr 29, 2026 ↗ |
| BlackRock, Inc. | 7.10% | 143.57M | 13G | Apr 17, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Sandra Leung | officer: EVP, General Counsel | 350.0K | 0.02% | Mar 12, 2025 |
| David V. Elkins | officer: EVP, Chief Financial Officer | 159.2K | 0.01% | Apr 2, 2026 |
| Christopher S. Boerner | director, officer: Chief Executive Officer | 129.5K | 0.01% | Mar 12, 2026 |
| Samit Hirawat | officer: EVP,Chief Med.Offr.,Drug Dev. | 83.5K | 0.00% | Apr 29, 2025 |
| Julia A. Haller | director | 34.1K | 0.00% | Jun 16, 2026 |
| Karin Shanahan | officer: EVP, Chief Supply Chain & Ops | 25.9K | 0.00% | Apr 2, 2026 |
| Cristian Massacesi | officer: EVP,Chief Med Offr,Head of Dev | 25.0K | 0.00% | Aug 4, 2026 |
| Gregory Scott Meyers | officer: EVP, Chief Digital & Tech Off. | 22.9K | 0.00% | Mar 12, 2026 |
| Adam Lenkowsky | officer: EVP, Chief Commercial Officer | 19.7K | 0.00% | May 5, 2026 |
| Phil M. Holzer | officer: SVP and Controller | 16.9K | 0.00% | Aug 26, 2026 |
1 ten-percent owner holds 7.01M shares by Form 4, outside the officers-and-directors figure above · 66 people have not refiled in the last 18 months (5.72M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 25, 2026 | Phil M. Holzerofficer: SVP and Controller | Sale | 500 | $67.50 | 16,862 |
| Apr 1, 2026 | David V. Elkinsofficer: EVP, Chief Financial Officer | Sale · 2 lots | 30,000 | $61.67 | 159,248 |
| Sep 2, 2025 | David V. Elkinsofficer: EVP, Chief Financial Officer | Sale | 56,000 | $47.33 | 167,379 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Sen. Tommy Tuberville · AL | Sale | $1,001 – $15,000 | Self | Apr 15, 2025 | Aug 5, 2026 ↗ |
| Rep. Mike Kelly · PA16 | Sale | $15,001 – $50,000 | Spouse | May 7, 2026 | Jun 12, 2026 ↗ |